Full name
KEDRION BIOPHARMA GMBH (SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ) ODDZIAŁ W POLSCE
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
2018 | 2019 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 7,2 | 3,6 | -49,8 |
EBITDA | 7,2 | 3,8 | -47,9 |
Short time liabilities | 6,7 | 11,7 | 76,5 |
Equity capital | 5,8 | 8,7 | 48,8 |
Operating profit (EBIT) | 7,2 | 3,8 | -47,7 |
Assets | 12,6 | 20,8 | 64,8 |
Net profit (loss) | 5,8 | 2,8 | -51,2 |
Cash | 0,1 | 0,1 | 58,5 |
Net income from sale | 38 | 45,9 | 20,8 |
Liabilities and provisions for liabilities | 6,8 | 12,2 | 78,5 |
Working assets | 12,6 | 20,8 | 64,8 |
Depreciation | 0 | 0 | -80,2 |
% | % | p.p. | |
Profitability of capital | 100 | 32,8 | -67,2 |
Equity capital to total assets | 46 | 41,5 | -4,5 |
Gross profit margin | 19 | 7,9 | -11,1 |
EBITDA Margin | 19,1 | 8,2 | -10,9 |
Days | Days | Days | |
Short term commitment turnover cycle | 64 | 93 | 29 |
Current financial liquidity indicator | 1.8488596677780151 | 1.7071560621261597 | -0,1 |
Net dept to EBITDA | 0.6450423002243042 | 2.2679874897003174 | 1,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane